13F

AORT ARTIVION INC

2026Q1 · CUSIP 228903100 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
237
Δ holders QoQ
-5
Breadth percentile
Top 78%
Whale holders
127
Δ whales
-4
Inst. holding value
$1.6B
New positions
37
Closed positions
42
Price momentum (1Q)
-34.9%
Put / Call
0/0

Breadth history (34 quarters)

2018Q1: Δ-5 · h=114 2018Q2: Δ+6 · h=120 2018Q3: Δ+14 · h=134 2018Q4: Δ+13 · h=147 2019Q1: Δ-2 · h=145 2019Q2: Δ+7 · h=152 2019Q3: Δ-13 · h=139 2019Q4: Δ-3 · h=136 2020Q1: Δ-7 · h=129 2020Q2: Δ-2 · h=127 2020Q3: Δ+3 · h=130 2020Q4: Δ+1 · h=131 2021Q1: Δ-5 · h=126 2021Q2: Δ+7 · h=133 2021Q3: Δ+3 · h=136 2021Q4: Δ-5 · h=131 2022Q1: Δ+5 · h=136 2022Q2: Δ-2 · h=134 2022Q3: Δ+3 · h=137 2022Q4: Δ+2 · h=139 2023Q1: Δ-4 · h=135 2023Q2: Δ-8 · h=127 2023Q3: Δ+16 · h=143 2023Q4: Δ-1 · h=142 2024Q1: Δ+12 · h=154 2024Q2: Δ+12 · h=166 2024Q3: Δ+9 · h=175 2024Q4: Δ+1 · h=176 2025Q1: Δ+9 · h=185 2025Q2: Δ+5 · h=190 2025Q3: Δ+29 · h=219 2025Q4: Δ+23 · h=242 2026Q1: Δ-5 · h=237 2018Q1: holders=114 2018Q2: holders=120 2018Q3: holders=134 2018Q4: holders=147 2019Q1: holders=145 2019Q2: holders=152 2019Q3: holders=139 2019Q4: holders=136 2020Q1: holders=129 2020Q2: holders=127 2020Q3: holders=130 2020Q4: holders=131 2021Q1: holders=126 2021Q2: holders=133 2021Q3: holders=136 2021Q4: holders=131 2022Q1: holders=136 2022Q2: holders=134 2022Q3: holders=137 2022Q4: holders=139 2023Q1: holders=135 2023Q2: holders=127 2023Q3: holders=143 2023Q4: holders=142 2024Q1: holders=154 2024Q2: holders=166 2024Q3: holders=175 2024Q4: holders=176 2025Q1: holders=185 2025Q2: holders=190 2025Q3: holders=219 2025Q4: holders=242 2026Q1: holders=237 -29 -14.5 +0 +14.5 +29 102179255 18Q119Q120Q121Q122Q123Q124Q125Q126Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 5 lit events

Period Percentile Next-1Q return Next-2Q return
2025Q3 Top 10% -15.8% -49.8%
2023Q3 Top 11% +32.7% +69.0%
2019Q2 Top 19% -4.9% +2.9%
2018Q4 Top 18% +1.7% -8.7%
2018Q3 Top 17% -1.8% -2.7%

Options Sentiment

Put holders
0
QoQ: 0
Call holders
0
QoQ: 0

See methodology →

Fundamentals

PE (TTM)
92.3
EPS (TTM)
$0.25
EPS YoY
Revenue (TTM)
$0.5B
Revenue YoY
+17.6%
Quarterly Revenue & EPS (4Y)
2022-06-30: $80M 2022-09-30: $77M 2022-12-31: $79M 2023-03-31: $83M 2023-06-30: $89M 2023-09-30: $88M 2023-12-31: $94M 2024-03-31: $97M 2024-06-30: $98M 2024-09-30: $96M 2024-12-31: $97M 2025-03-31: $99M 2025-06-30: $113M 2025-09-30: $113M 2025-12-31: $116M 2026-03-31: $116M 2022-06-30: EPS -0.11 2022-09-30: EPS -0.34 2022-12-31: EPS 0.05 2023-03-31: EPS -0.33 2023-06-30: EPS -0.08 2023-09-30: EPS -0.24 2023-12-31: EPS -0.10 2024-03-31: EPS 0.18 2024-06-30: EPS -0.05 2024-09-30: EPS -0.05 2024-12-31: EPS -0.40 2025-03-31: EPS -0.01 2025-06-30: EPS 0.03 2025-09-30: EPS 0.13 2025-12-31: EPS 0.06 2026-03-31: EPS 0.03 0M 58M 116M $M -0.44 -0.12 0.20 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 174 2025-12-31: PE 174.32026-03-31: PE 91.1 82 133 183 20222023202420252026

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)